Provisional Patent Filed on Non-Racemic Ibogaine Mixtures VANCOUVER, BC, March 2, 2022 /CNW/ – Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) (FRA: 6MH) (“MINDCURE” or the “Company”), a leader in advanced proprietary technology for mental health care and research in psychedelics, announced today that it has developed a number of non-racemic mixtures of ibogaine and has filed a provisional patent…


Previous articleField Trip Health and Cerebral Partner to Provide End-to-End Mental Health Care
Next articleThe Need for an International Psychedelic Religious Survey